SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents
2 references·8 citing·26 second hop
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents (2017)Association of Patient Out-of-Pocket Cost…Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Measuring financial toxicity …The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions (2023)Financial Toxicity in Cancer …Many Medicare Beneficiaries Do Not Fill High-Price Specialty Drug Prescriptions (2022)Many Medicare Beneficiaries D…Risk factors for financial toxicity in patients with gynecologic cancer (2021)Risk factors for financial to…Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem (2021)Levine Cancer Institute Finan…Worry About Daily Financial Needs and Food Insecurity Among Cancer Survivors in the United States (2020)Worry About Daily Financial N…Financial Hardship, Healthcare Utilization, and Health Among U.S. Cancer Survivors (2020)Financial Hardship, Healthcar…Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation (2019)Understanding Financial Hards…Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement (2018)Addressing Financial Barriers…A new scale of social desirability independent of psychopathology. (1960)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment (2018)Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention (2019)Age-Related Differences in Financial Toxicity and Unmet Resource Needs Among Adolescent and Young Adult Cancer Patients (2019)Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care (2022)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Financial Impact of Breast Cancer in Black Versus White Women (2018)Potential impact of the COVID ‐19 pandemic on financial toxicity in cancer survivors (2020)Association of Medical Financial Hardship and Mortality Among Cancer Survivors in the United States (2022)Closing the gap in a generation: health equity through action on the social determinants of health (2008)Closing the gap in a generation: health equity through action on the social determinants of health (2009)S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients (2021)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Analysis of patient experiences with gestational trophoblastic neoplasia reported on Instagram social media (2022)Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions (2011)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment (2018)Association Between Social Determinants of Health and Cancer Treatment Delay in an Urban Population (2024)
this work references cited by second hop

References

  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,133 cited
  • 2016Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)928 cited

Cited by

  • 2019Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation151 cited
  • 2023Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions122 cited
  • 2018Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement91 cited
  • 2020Financial Hardship, Healthcare Utilization, and Health Among U.S. Cancer Survivors85 cited
  • 2022Many Medicare Beneficiaries Do Not Fill High-Price Specialty Drug Prescriptions82 cited
  • 2020Worry About Daily Financial Needs and Food Insecurity Among Cancer Survivors in the United States80 cited
  • 2021Risk factors for financial toxicity in patients with gynecologic cancer61 cited
  • 2021Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem56 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work